
Healthcare AI
SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
Lucas RopekTechCrunch AI
AI Summary
SandboxAQ is integrating its drug discovery models with Claude to make advanced computational drug discovery more accessible to researchers without specialized computing expertise. The company believes that democratizing access to AI models, rather than just building better models, is the key competitive advantage in the drug discovery space.
This article was originally published on TechCrunch AI. Read the full story at the source.
Read Full Article at TechCrunch AIRelated Articles

OpenAI is giving away its life sciences AI model to help governments prepare for the next pandemic
The Decoder
Boston Children’s uses AI to unlock new diagnoses
OpenAI Blog
Strengthening societal resilience with Rosalind Biodefense
OpenAI Blog

AI-hallucinated citations are creeping into papers that shape clinical guidelines, researchers warn
The Decoder